Investors sold shares of Johnson & Johnson (NYSE:JNJ) on strength during trading hours on Tuesday. $141.98 million flowed into the stock on the tick-up and $481.16 million flowed out of the stock on the tick-down, for a money net flow of $339.18 million out of the stock. Of all stocks tracked, Johnson & Johnson had the 0th highest net out-flow for the day. Johnson & Johnson traded up $1.46 for the day and closed at $142.60

Several brokerages have recently issued reports on JNJ. Piper Jaffray Companies restated a “hold” rating and issued a $120.00 price objective on shares of Johnson & Johnson in a research note on Wednesday, October 4th. Vetr downgraded shares of Johnson & Johnson from a “hold” rating to a “sell” rating and set a $130.49 price objective on the stock. in a research note on Monday, September 18th. Stifel Nicolaus raised their price objective on shares of Johnson & Johnson from $140.00 to $142.00 and gave the stock a “hold” rating in a research note on Wednesday, October 18th. UBS restated a “buy” rating and issued a $148.00 price objective on shares of Johnson & Johnson in a research note on Thursday, August 31st. Finally, Wells Fargo & Company upgraded shares of Johnson & Johnson from a “market perform” rating to an “outperform” rating and raised their price objective for the stock from $140.00 to $149.00 in a research note on Monday, October 9th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eleven have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $145.04.

The firm has a market capitalization of $383,702.22, a price-to-earnings ratio of 20.00, a PEG ratio of 2.90 and a beta of 0.80. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.02 and a current ratio of 1.32.

Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings data on Tuesday, October 17th. The company reported $1.90 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.80 by $0.10. The company had revenue of $19.65 billion during the quarter, compared to analysts’ expectations of $19.29 billion. Johnson & Johnson had a return on equity of 27.38% and a net margin of 21.28%. The business’s revenue was up 10.3% on a year-over-year basis. During the same period last year, the business earned $1.68 earnings per share. equities research analysts anticipate that Johnson & Johnson will post 7.28 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Tuesday, November 28th were issued a dividend of $0.84 per share. The ex-dividend date was Monday, November 27th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.35%. Johnson & Johnson’s payout ratio is presently 58.33%.

Hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. raised its holdings in shares of Johnson & Johnson by 1.5% in the second quarter. Vanguard Group Inc. now owns 200,450,985 shares of the company’s stock valued at $26,517,661,000 after buying an additional 3,023,110 shares during the last quarter. BlackRock Inc. raised its holdings in shares of Johnson & Johnson by 2.6% in the second quarter. BlackRock Inc. now owns 174,073,764 shares of the company’s stock valued at $23,028,219,000 after buying an additional 4,332,612 shares during the last quarter. State Street Corp raised its holdings in shares of Johnson & Johnson by 4.3% in the first quarter. State Street Corp now owns 160,223,321 shares of the company’s stock valued at $19,955,806,000 after buying an additional 6,656,371 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Johnson & Johnson by 0.4% in the third quarter. Bank of New York Mellon Corp now owns 36,594,054 shares of the company’s stock valued at $4,757,593,000 after buying an additional 130,437 shares during the last quarter. Finally, FMR LLC raised its holdings in shares of Johnson & Johnson by 5.9% in the second quarter. FMR LLC now owns 27,237,648 shares of the company’s stock valued at $3,603,268,000 after buying an additional 1,509,745 shares during the last quarter. 65.89% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another site, it was illegally stolen and reposted in violation of US and international trademark & copyright law. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/12/14/traders-sell-shares-of-johnson-johnson-jnj-on-strength-jnj-2.html.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.